The Australian market settled in red on 2nd March 2020 and the S&P/ASX200 closed at 6391.5, reflecting a decline of 49.7 points. At the close of session, S&P/ASX 200 Health Care (Sector) stood at 43,474.7 with a fall of 342.1 points and S&P/ASX 200 Financials (Sector) settled with a fall of 1.51% to 5,816.6. At the close of same trading day, All Ordinaries witnessed a decline of 50.4 points and stood at 6461.1.
Let us now look at the performance of some companies, which ended in green despite the fall in market. WiseTech Global Limited (ASX: WTC) experienced a rise of 12.715% and stood at $17.020 per share. PolyNovo Limited (ASX: PNV) closed at $2.460 per share with an increase of 7.424%.
Moving towards the losers and gainers at NZX Main Board, Geo Limited (NZX: GEO) soared by 7.69% and settled the session at NZ$0.070. TruScreen Limited (NZX: TRU) rose by 3.66% to NZ$0.085 per share. When it comes to losers, SeaDragon Limited (NZX: SEA) tumbled by 50.00% and closed at NZ$0.001.
Recently, we have covered important information on Japara Healthcare Limited (ASX:JHC). Please click here to read the article.
WiseTech Global Limited Settled in green on Australian Stock Exchange
WiseTech Global Limited (ASX:WTC) recently released its results for the first half of financial year 2020, wherein it reported a rise of 31% in revenue to $205.9 million. The revenue growth has been generated by continued strong organic growth throughout its global business and the addition of more than 450 internally developed product enhancements. EBITDA for the period stood at $62.5 million with an increase of 29%. These results reflect strength of its CargoWise business and strategic actions. The company reported a growth of 24% in organic revenue from existing and new CargoWise customers. Moreover, revenue from customers on acquired platforms increased by $24.9 million, which was mainly fuelled by the full period impact of acquisitions completed in FY19.
During the span of last five years, the company had invested more than $360 million in product innovation, adding 3,500 product enhancements to its global platform. The Board declared fully franked interim dividend of 1.70 cents per share. For FY20, the company is expecting revenue in the range of $420 million to $450 million with the expected growth of between 21%-29%. WTC anticipates EBITDA in between 114 million to $132 million with the growth of 5%-22%.
PolyNovo Limited reported higher sales in 1H FY20
PolyNovo Limited (ASX:PNV), on 2nd March 2020, announced that Mr David Williams has made a change to holdings in the company on 27th February 2020 by acquiring 100,000 ordinary fully paid shares. For the half-year ended 2020, the company reported an increase of 129% in NovoSorb BTM sales against 1H FY19. PNV anticipates double sales of NovoSorb BTM sales for FY20.